Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation

Bone Marrow Transplantation

Volumn 25, Issue 2, 2000, Pages 147-152

  Kapur, D ^a   Dorsky, D ^a   Feingold, J M ^a   Bona, R D ^a   Edwards, R L ^a   Aslanzadeh, J ^a   Tutschka, P J ^a   Bilgrami, S ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Autologous stem cell transplant; Vancomycin resistant enterococcus

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; CHLORAMPHENICOL; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; NITROFURANTOIN; POLYPEPTIDE ANTIBIOTIC AGENT; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIUM ISOLATE; CAUSE OF DEATH; CHILD; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RECIPIENT; RELAPSE; RETROSPECTIVE STUDY; SCHOOL CHILD;

EID: 0033972772     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702123     Document Type: Article

References (36)

1. Englehard D, Monks MI, Good RAE. Infections in bone marrow transplant recipients. J Pediatr 1986; 108: 335-346.
2. Walter EA, Bowden RA. Infections in the bone marrow transplant recipient. Infect Dis Clin North Am 1995; 4: 823-847.
3. Bilgrami S, Feingold JM, Dorsky D et al. Streptococcus viridans bacteremia following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 1998; 21: 591-595.
4. Schaherg DR, Culver DH, Gaynes RP. Major trends in microbial etiology of nosocomial infection. Am J Med 1991; 91 (Suppl. 3B): 72S-75S.
5. Morris JG Jr, Shay DK, Hehden JN et al. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med 1995; 123: 250-259.
6. Wade JJ, Rolando N, Hayllar K et al. Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 1995; 21: 1328-1336.
7. Chakraborty NG, Bilgrami S, Maness LJ et al. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome. Bone Marrow Transplant 1999; 24: 837-843.
8. National Committee for Clinical Laboratory Procedures. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 3d edn. National Committee for Clinical Laboratory Standards: Villanova, PA, 1993.
9. National Committee for Clinical Laboratory Procedures. Performance Standards for Antimicrobial Disk Susceptibility Tests, 5th edn. National Committee for Clinical Laboratory Standards: Villanova, PA, 1993.
10. Jett BD, Huycke MM, Gilmore MS. Virulence of enterococci. Clin Microbiol Rev 1994; 7: 462-478.
11. Murray BE. The life and times of enterococcus. Clin Microbiol Rev 1990; 3: 46-65.
12. Clark NC, Cooksey RC, Hill BC et al. Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrob Agents Chemother 1993; 37: 2311-2317.
13. Chadwick PR, Oppenheim BA. Fox A et al. Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukemia unit. J Hosp Infect 1996; 34: 171-182.
14. Papanicolaou GA, Meyers BR, Meyers J et al. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality. Clin Infect Dis 1996; 23: 760-766.
15. Spera RV Jr, Farber BF. Multiply-resistant Enterococcus faecium. The nosocomial pathogen of the 1990s. JAMA 1992; 268: 2563-2564.
16. Montecalvo MA, Horowitz, H. Gedris C et al. Outbreak of vancomycin-, ampicllin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother 1994; 38: 1363-1367.
17. Edmond MB, Ober JF, Weinbaum DE et al. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis 1995; 20: 1126-1133.
18. Patterson JE, Sweeny AH, Simms M et al. An analysis of 110 serious enteroccoccal infections. Medicine 1995; 75: 191-200.
19. Linden PK, Pasculle AW, Manez R et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceplible E. faecium. Clin Infect Dis 1996; 22: 663-670.
20. Elishoov H, Or R, Strauss N et al. Nosocomial colonization, septicemia, and Hickman/Broviac catheter-related infections in bone marrow transplantation recipients: a 5 year prospective study. Medicine 1998; 77: 83-101.
21. Tornieporth NG, Roberts RB, John J et al. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996; 23: 767-772.
22. Norris AH, Reilly JP, Edelstein PH et al. Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections. Clim Infect Dis 1995; 20: 1137-1144.
23. Moreno F, Jorgensen JH, Weiner MH. An old antibiotic for a new multiple-resistant Enterococcus faecium. Diagn Microbiol Infect Dis 1994; 20: 41-43.
24. Moellering RC Jr. Vancomycin-resistant enterococci. Clin Infect Dis 1998; 26: 1196-1199.
25. Chia JKS, Nakata MM. Park SS et al. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium. Clin Infect Dis 1995; 21: 1520 (letter).
26. O'Donovan CA, Fan-Havard P, Tecson-Tumang FT et al. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994; 18: 105-109.
27. Lai KK. Treatment of vancomycin-resistant Enterococcus faecium infections. Arch Intern Med 1996; 156: 2579-2584.
28. Eliopoulos GM, Wennersten CB, Gold HS et al. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin. Antimicrob Agents Chemother 1998; 42: 1088-1092.
29. Centers for Disease Control and Prevention. Nosocomial enterococci resistant to vancomycin - United States 1989-1993. Morb Mortal Wkly Rep 1993; 42: 597-599.
30. Gregory JJ, Small TN, Papadopoulos E et al. Influence of vancomycin-resistant enterococcus on the outcome of recipients of bone marrow transplants. Proc Am Soc Clin Oncol 1999; 18: 51a (Abstr.).
31. Noskins GA, Stosor V, Cooper I, Peterson LR. Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces. Infect Control Hosp Epidemiol 1995; 16: 577-581.
32. Rhinehart E, Smith NE, Wennersten C et al. Rapid dissemination of B-lactamase-producing, aminoglycocide-resistant Enterocuccus faecalis among patients and staff of an infant-toddler surgical ward. New Engl J Med 1990; 323: 1814-1818.
33. Karanfil LV, Murphy M, Josephson A et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992; 13: 195-200.
34. Livornese LL Jr, Dias S, Samel C et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117: 112-116.
35. Boyce JM, Opal SM, Chow JW et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994; 32: 1148-1153.
36. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995; 16: 105-113.